BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Somaxon, P&G sales and marketing update

Somaxon launched its Silenor doxepin in the U.S. to treat insomnia characterized by difficulty with sleep maintenance....

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >